REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
NCT ID: NCT05345483
Last Updated: 2024-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
153 participants
OBSERVATIONAL
2023-01-25
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter
Rescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years old
* With acute persistent vascular occlusion due to high grade intracranial artery stenosis in the anterior or posterior circulation for which alternative therapy concepts are not considered or fail
* With suspected underlying stenosis of the occluded artery, which is suitable for PTA and stenting according to the treating physician's assessment and/or persistent occlusion after failed recanalization by mechanical thrombectomy of the target region
* With small to moderate infarct core prior to initiation of thrombectomy (CT ASPECTS 6-10, DWI lesion \< 70 ml)
* With symptoms onset less than 24 hours before start of the procedure
* Treated with study device following at least one futile mechanical recanalization attempt with a stent retriever, direct aspiration or combination of both
* With pre-stroke disability mRS 0-2
Exclusion Criteria
* With atherosclerotic (probable according to clinical, anamnestic or laboratory chemical testing) vessel constrictions (high-grade intracranial stenoses \> 70 %) with significant circulatory disturbance (haemodynamic infarct pattern and signs of restricted collaterals) and recurrent symptoms in spite of medical therapy
* With contraindication against treatment with anti-platelet medication
* Participating in another trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acandis GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut für Radiologie und Neuroradiologie, Klinikum Aschaffenburg-Alzenau
Aschaffenburg, , Germany
Klinik für Diagnostische Radiologie und Neuroradiologie; Universitätsklinikum Augsburg
Augsburg, , Germany
Klinik für Diagnostische und Interventionelle Neuroradiologie; Universitätsklinikum Bonn
Bonn, , Germany
Institut für Diagnostische und Interventionelle Radiologie, Neuroradiologie und Nuklearmedizin, Klinikum Bremerhaven-Reinkenheide
Bremerhaven, , Germany
Institut und Poliklinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum Dresden
Dresden, , Germany
Klinik für Radiologie und Neuroradiologie, Sana Klinikum
Duisburg, , Germany
Diagnostische und interventionelle Radiologie, Helios Klinikum Erfurt
Erfurt, , Germany
Diagnostische und Interventionelle Neuroradiologie, Universitätsmedizin Halle
Halle, , Germany
Abteilung für Radiologie, Neuroradiologie und Nuklearmedizin, Asklepios Klinikum Altona
Hamburg, , Germany
Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf
Hamburg, , Germany
Radiologie / Neuroradiologie, Askleopis Klinik St. Georg
Hamburg, , Germany
Klinik für Neuroradiologie, Westpfalz-Klinikum
Kaiserslautern, , Germany
Abteilung für Radiologie und Nuklearmedizin, Sana Kliniken
Lübeck, , Germany
Interventionelle Neuroradiologie, Universitätsklinikum Münster
Münster, , Germany
Institut für Radiologie und Neuroradiologie, Evangelisches Krankenhaus Oldenburg
Oldenburg, , Germany
Klinik für Radiologie, Neuroradiologie und Nuklearmedizin, Klinikum Vest
Recklinghausen, , Germany
Institut für Diagnostische und Interventionelle Neuroradiologie, Städtisches Klinikum
Solingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
PD Dr. med. Volker Maus
Role: primary
Prof. Dr. med. Ansgar Berlis
Role: primary
Prof. Dr. med. Franziska Dorn
Role: primary
Dr. med. Timo Phung
Role: primary
Dr. med. Johannes Gerber
Role: primary
Dr. med. Martin Schlunz-Hendann
Role: primary
PD Dr. med. Donald Lobsien
Role: primary
PD Dr. med. Stefan Schob
Role: primary
Prof. Dr. med. Bernd Eckert
Role: primary
Dr. med. Maxim Bester
Role: primary
Dr. med. Jan-Hendrik Buhk
Role: primary
Dr. med. Andreas Simgen
Role: primary
Dr. med. Christian Dyzmann
Role: primary
Dr. med. Christian-Paul Stracke
Role: primary
PD Dr. med. Christian Mathys
Role: primary
Dr. med. Christian Loehr
Role: primary
Dr. med. Hannes Nordmeyer, PI
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHRUT
Identifier Type: -
Identifier Source: org_study_id